Charles B. Simone, II, MD, FACRO
Charles B. Simone, II, MD, FACRO is a Research Professor and the Chief Medical Officer of the New York Proton Center and a Full Member in the Department of Radiation Oncology at Memorial Sloan Kettering Cancer Center. He is an internationally recognized expert in the use of proton therapy to treat thoracic malignancies and for reirradiation, and in the development of clinical trial strategies and innovative research in thoracic radiation oncology and stereotactic body radiation therapy. He is a National Institutes of Health, National Science Foundation, and Department of Defense funded investigator who performs clinical and translational research investigating the benefits of proton therapy as part of multi-modality therapy for lung cancer, malignant pleural mesothelioma, and other thoracic malignancies.
Prior to coming to NYPC, Dr. Simone was Chief of the Thoracic Oncology Service at the Hospital of the University of Pennsylvania, Director of the Penn Mesothelioma and Pleural Program, and Director of Clinical Research and Operations in the Department of Radiation Oncology at Penn. He was then appointed Medical Director of the Maryland Proton Treatment Center, and at the University of Maryland, he also served as Chair of the Clinical Research Committee for their Comprehensive Cancer Center, proton therapy Fellowship Director, and Director of the Stereotactic Radiation Therapy Program. He completed his undergraduate and medical school training at the University of Pennsylvania, internship in internal medicine, and residency training in radiation oncology at the National Cancer Institute, NIH, where he served as chief resident.
Dr. Simone has published >320 peer-reviewed scientific articles and book chapters, given >200 scientific lectures to national and international audiences, and is the national Principal Investigator or Co-Chair of 7 NIH-funded cooperative group trials (4 NRG Oncology, 1 SWOG, 1 ECOG-ACRIN, 1 PCG). He is a three-time winner of the Association of Residents in Radiation Oncology (ARRO) Educator of the Year Award. Dr. Simone Chairs or Co-Chairs the Proton Collaborative Group (PCG) Executive Committee; PCG Lung Committee; American Society for Radiation Oncology (ASTRO) Lung Resource Panel Committee; ASTRO Small Cell Lung Cancer Guidelines Committee; American Radium Society-American College of Radiology (ARS-ACR) Appropriate Use Criteria Thoracic Committee; Particle Therapy Co-Operative Group (PTCOG) Gastrointestinal Subcommittee; PTCOG Skull Base/Central Nervous System, Sarcoma Subcommittee; American College of Radiation Oncology (ACRO) Recruitment Subcommittee; ACRO Annual Meeting Abstracts Committee; and National Cancer Institute/Radiosurgery Society (RSS) GRID-Lattice-Microbeam-Flash Radiotherapy Clinical Working Group. He is the Editor-in-Chief of Annals of Palliative Medicine and on the Editorial Boards of Journal of Clinical Oncology, Journal of Thoracic Disease, Frontiers in Oncology, Translational Lung Cancer Research, Annals of Translational Medicine, Therapeutic Radiology and Oncology, and Shanghai Chest.
Zhi-hua Zhu, MD, PhD
Zhi-hua Zhu, MD, PhD, is an associate professor in State Key Laboratory of Oncology in South China, Cancer Center, Sun Yat-sen University. Dr. Zhu received his M.D. degree and then trained as a postdoctoral fellow in Sun Yat-sen University. Dr. Zhu has actively been engaged in the pre-clinical and clinical studies on chest tumors including lung cancer, esophageal carcinoma, and breast cancer, with special interests in the palliative treatment of tumors and the individualized treatment of lung cancers. Dr. Zhu has participated in the National 863 key Program on ‘Molecular Typing and Individualized Treatment of Lung Cancer and Esophageal Carcinoma’. Furthermore, Dr. Zhu is the responsible person for a number of research projects supported by National Natural Science Fund, Ministry of Human Resources, and many other State- and province-level institutions. He has served as a fellow or visiting scholar in the United States in 2009 and in France and Germany in 2010. Dr. Zhu has published articles in Journal of Clinical Oncology (Zhu ZH, et al. Three immunomarker support vector machines-based prognostic classifiers for stage IB non-small-cell lung cancer. J Clin Oncol. 2009;27:1091-9.), Journal of Cancer Research and Clinical Oncology, World Journal of Gastroenterology, Medical Oncology, and many other peer-reviewed journals. Dr. Zhu is a member of the editorial committee of Journal of Thoracic Disease and an expert evaluator for Research Fund for the Doctoral Program of Higher Education of China. He won the ‘Ding Ying Science and Technology Award’ issued by the Province of Guangdong in 2010.